SLC16A1 and esophageal adenocarcinoma: In a large cohort study of operated gastric cancer patients, MCT1 expression was associated with a higher T-class, but not with prognosis [12], and in esophageal adenocarcinoma, a high MCT1 expression was associated with an improved prognosis [6].